Overview of Dr. Yamoah
Dr. Kosj Yamoah is a radiation oncologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. He received his medical degree from Icahn School of Medicine at Mount Sinai and has been in practice 12 years. He is one of 67 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Radiation Oncology. He has more than 100 publications and over 500 citings.
Office
12902 USF Magnolia Dr
Tampa, FL 33612
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Radiation Oncology, 2011 - 2015
Atlantic Health SystemInternship, Transitional Year, 2010 - 2011
Icahn School of Medicine at Mount SinaiClass of 2010
Certifications & Licensure
FL State Medical License 2015 - 2025
PA State Medical License 2011 - 2015
MO State Medical License 2013 - 2014- American Board of Radiology Radiation Oncology
Clinical Trials
- Validation Study on the Impact of Decipher® Testing - VANDAAM Study Start of enrollment: 2016 Apr 13
- PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores Start of enrollment: 2019 Dec 18
- Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy Start of enrollment: 2018 Oct 03
Publications & Presentations
PubMed
- A Single Institution Experience in the Management of Localized Neuroendocrine Carcinoma of the Bladder.Casey Liveringhouse, Austin J Sim, Jingsong Zhang, Rohit K Jain, Shreyas U Naidu
Clinical Genitourinary Cancer. 2024-12-01 - The Need to Enrich Population Diversity in Radiogenomic Research.Barry S Rosenstein, Kosj Yamoah, Søren M Bentzen, Sarah L Kerns, J Tyson McDonald
International Journal of Radiation Oncology, Biology, Physics. 2024-11-15 - Oncogenic Alterations, Race, and Survival in US Veterans with Metastatic Prostate Cancer Undergoing Somatic Tumor Next Generation Sequencing.Luca F Valle, Jiannong Li, Heena Desai, Ryan Hausler, Candace Haroldsen
Biorxiv. 2024-10-25
Authored Content
- Who Needs Early Salvage RT and Who Needs Adjuvant RT in 2022? With Dr Kosj YamoahAugust 2022
- Who Needs Early Salvage Radiotherapy and Who Needs Adjuvant Radiotherapy in 2022? - Kosj YamoahJuly 2022
Press Mentions
Veracyte’s RNA Genetic Test Predicts Black Men’s Aggressive Prostate CancerOctober 3rd, 2024- New Data Presented at ASTRO 2024 Show That Veracyte’s Decipher Prostate Test Predicts Aggressive Prostate Cancer in African American MenOctober 2nd, 2024
- Genomic Testing Can Identify African American Prostate Cancer Patients Who Have High-Risk DiseaseSeptember 23rd, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
